Diagnostyka S.A.
Research Diagnostyka S.A. (7JS) on Bullrun: market cap EUR 1.28B, P/E 21.2, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7JS
- ExchangeF
- CountryPoland
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 1.28B
- P/E21.2
- Dividend yield2.7%
- Financial periodQ1 2026
- RevenueEUR 670.92M
- Net incomeEUR 82.55M
- Free cash flowEUR 110.29M
- Gross margin79.3%
Valuation Snapshot
latest market cap is EUR 1.28B; P/E is 21.2; dividend yield is 2.7%.
Peer valuation comparison
Latest P/E is 21.2x versus a Healthcare sector median of 23.83x (11.1% below).
Latest dividend yield is 2.65% versus a Healthcare sector median of 2.17% (22.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 2.41B | EUR 251.60M | EUR 346.99M | 57.3% | n/a | EUR 18.42M | EUR 1.08B | EUR 528.40M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-07-29 | EUR 1.28B | 21.2 | 2.8% | 1.03 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.03 EUR, yield 2.7%.
About Diagnostyka S.A.
Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Diagnostyka S.A.'s market cap?
Diagnostyka S.A.'s market capitalization is EUR 1.28B.
What is Diagnostyka S.A.'s P/E ratio?
Diagnostyka S.A.'s price-to-earnings (P/E) ratio is 21.2.
Does Diagnostyka S.A. pay a dividend?
Diagnostyka S.A. has a dividend yield of 2.7%.
What does Diagnostyka S.A. do?
Diagnostyka S.A. provides diagnostic services in Poland. The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests. The company provides services to individual clients, and public and private entities. Diagnostyka S.A.